Altered RNA splicing initiates the viral mimicry response from inverted SINEs following type I PRMT inhibition in Triple-Negative Breast Cancer
C.H. Arrowsmith(University Health Network), Mathieu Lupien(Ontario Institute for Cancer Research), Benjamin Haibe‐Kains(University of Toronto), Jennifer Cruickshank(Ontario Institute for Cancer Research), YiShuai Ji(Zhejiang Cancer Hospital), Sajid A. Marhon(University of Pennsylvania), Jillian Haight(University Health Network), Jing Liu(Sichuan University), Dalia Baršytė-Lovejoy(University Health Network), Lan-Xin Zhang(University of Toronto), Magdalena M. Szewczyk(University of Toronto), Shili Duan(Ontario Institute for Cancer Research), Jian Jin(Icahn School of Medicine at Mount Sinai), David W. Cescon(Princess Margaret Hospital), Panagiotis Prinos(University of Toronto), Daniel D. De Carvalho(University Health Network), Nergiz Artun(University Health Network), Geneviève Deblois(Institute for Research in Immunology and Cancer), Felipe E. Ciamponi(Universidade Estadual de Campinas (UNICAMP)), Katlin Maussirer(Universidade Estadual de Campinas (UNICAMP)), Qin Wu(Chinese Academy of Sciences), Wail alawi(University Health Network), Wenjun Chen(Sir Run Run Shaw Hospital), Parinaz Mehdipour(University Health Network), Yudao Shen(Icahn School of Medicine at Mount Sinai), Jocelyn Chen(University Health Network)
Cited by 1
Related Papers
Epigenetic protein families: a new frontier for drug discovery
|Nature Reviews Drug Discovery|2012|1.3k
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848